TBPH icon

Theravance Biopharma

94 hedge funds and large institutions have $722M invested in Theravance Biopharma in 2014 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$131K
Puts
$135K
Net Calls
Net Calls Change

Top Buyers

1 +$193M
2 +$66.5M
3 +$66M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$43.7M
5
O
OppenheimerFunds
New York
+$34.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
76
$188K
77
$182K
78
$135K
79
$112K
80
$76K
81
$64K
82
$50K
83
$35K
84
$28K
85
$27K
86
$23K
87
$21K
88
$10K
89
$6K
90
$2K
91
$1.82K
92
$1K